Bayer HealthCare Pharmaceuticals gave grants totaling $2.75 million to 26 international hemophilia healthcare professionals and caregiver educators, as part of the 2006 Bayer Hemophilia Awards Program (BHAP). Awards support individuals pursuing bleeding disorders research or developing innovative educational programs. The winners, including five Americans, were honored on May 23rd with an awards dinner and ceremony at the 2006 World Federation of Hemophilia Annual Congress in Vancouver, British Columbia.
 
Winners were selected by a 13-member grant review and award committee composed of clinicians and hemophilia researchers. The  committee chair was David Lillicrap, MD, Professor in the Department of Pathology and Molecular Medicine at Queen's University in Ontario, Canada. "We need programs like BHAP because of a shortage of important funding for hemophilia research. Bayer's awards help encourage young, bright researchers, clinicians, and caregivers to focus their careers on hemophilia," he said .

Source: Bayer HealthCare news release dated May 23, 2006